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ABSTRACT
One of the most critical structures in cellular biology is the plasma
membrane, due to its ability to respond to environmental stresses.
Saccharomyces cerevisiae is a model, single-celled eukaryote that has
been used to investigate many aspects of cell biology. A recent genetic
screen in yeast for plasma membrane homeostatic proteins identified
three related proteins of unknown molecular function that participate in
these processes. These proteins, termed PDR19, PDR20, and PDR21 for
Pleiotropic Drug Resistance, are each approximately one hundred amino
acids in size and share a small conserved domain, namely the core
sequence KITRYDL. In the case of PDR21, the core sequence is
VITRHDL. The coding sequences for this set of proteins are found in the
ORFs YGR035c, YLR346c and YPR145w-a, respectively. A triple
mutation of these genes led to an observed decrease in membrane
homeostasis, when cells were treated with the membrane- disrupting
compound digitonin, natural products that disturb membranes and in the
presence of the clinical antifungal drug amphotericin B. The observed
phenotype suggests this set of novel proteins functionally regulate
membranes in response to membrane-altering conditions, as an observed
fifty-fold increase in membrane sensitivity of the triple mutant was
observed. In order to help determine the molecular function(s) of the PDR
proteins, a GAL4 two-hybrid system is being used to screen for proteins
that may associate with the PDR 19/20/21 family proteins and help

mediate their cellular functions. That this system can be used has been
confirmed through negative autoactivation tests involving a Gal4DBD-PDR
fusion construct and done in a modified Y187/Y190 mating strain carrying
the pACT II activation domain plasmid containing the ADGal4. Plasmid
sequencing of the Gal4DBD-PDR fusion proteins is in process to help
confirm proper cloning of the bait proteins in addition to library screening.
In addition to this work, bioinformatic characterization of genes involved in
TTG cellular responses was conducted. In a previous screen in the
Erdman lab, 4,851 deletion strains were screened, of which 991 strains
demonstrated a degree of sensitivity or resistance to TTGs. In an attempt
to further understand and classify these results, a bioinformatics tool was
used to reveal underlying modes of genetic control governing the range of
observed phenotypic sensitivities.
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INTRODUCTION
Perhaps one of the most crucial structures in cellular biology is the
plasma membrane, because of its ability to respond to environmental
stresses. This is particularly the case with Saccharomyces cerevisiae, as
they are single-celled eukaryotes that naturally remain in contact with the
surrounding environment. In order to regulate, and often times resist,
environmental challenges such as osmotic pressure and chemical uptake,
many cellular organisms adapt specialized plasma membranes, as is the
case with S. cerevisiae. The plasma membrane classically consists of a
lipid bilayer membrane with distinct regions of hydrophillicity and
hydrophobicity. In addition to the presence of phospholipids, several other
components, such as sterols, provide structural support and fluidity to a
membrane bilayer. Moreover, several gene products regulate ion and
molecular channels in yeast membranes, as well as signal transduction
associated with changes in permeability. These components of the
plasma membrane rarely act alone, often inducing multiple pathways. The
specific mechanisms of plasma membrane structure, fluidity, and channel
regulation are of interest, for most biological systems have evolutionarily
adopted the plasma membrane with little variation. S. cerevisiae is an
ideal experimental model system used in studying such underlying
membrane mechanisms, due to its ease of genetic manipulation and
analysis of phenotypic expression. Understanding the mechanisms and
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genetic components regulating membrane permeability and homeostasis
will lead to a greater understanding in related biological systems.

PLASMA MEMBRANE STRUCTURE
The outermost layer of the cellular envelope in yeast is the cell wall.
Essentially, this structure provides support and rigidity to the entire cell.
Beneath the cell wall is the plasma membrane, which is responsible for
providing a semi-permeable barrier for hydrophobic molecules greater
than 600 Da[7]. The plasma membrane is composed of several different
types of lipids, which possess different chemical and physical properties.
This finding suggests a possible mechanism by which proteins within the
membrane associate with distinct lipids[7]. One of the largest classes of
lipids present in the membrane by percentage is the sphingolipids. They
may contribute as much as thirty percent of the total phospholipid content
present in the plasma membrane[7]. The fatty acid chains present in the
plasma membrane of S. cerevisiae largely include oleic acid (18:1) and
palmitoleic acid (16:1) [7]. Essentially the packing level of these fatty acyl
chains is what contributes to the overall fluidity of the plasma membrane.
Tight packing of the fatty acyl chains results from increases in acyl chain
length and consequently favors a membrane that is relatively more rigid,
disallowing extensive lateral movement or permeation by hydrophobic
solutes. Equally important for the physical attraction of proteins, the head
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groups present on the lipids influence membrane proteins, as well as the
overall electrical potential of the membrane.
While the membrane largely consists of a phospholipid bilayer,
several integral proteins and sterol molecules play a key role in
transporting solute molecules across the membrane. Through vesicular
transport, proteins are produced on rough endoplasmic reticulum and
travel to the plasma membrane. Transport vesicles bud off of the ER and
fuse with the Golgi apparatus, initiated by a Ras-type GTP binding
protein[7]. Through a GDP-GTP exchange protein the SAR1 protein
becomes active, thereby initiating vesicular budding from the ER. The
GTP is consequently hydrolyzed upon completion of the formation of the
vesicle[7]. Like most cellular processes, vesicular trafficking and
membrane construction is the result of several interacting genetic
pathways and gene products. For instance, a single mutation in the GTPbinding protein, Ypt1p, results in the consequential buildup of membranes
within the cell[7]. In mammalian cells, the vesicular fusion process is
similar, but involves three complexes known as SNAPs, v-SNARE, and
the target fusion membrane, t-SNARE[7].
Several key proteins remain in contact with the plasma membrane.
These proteins allow for ATP binding, diffusion, and other types of
transport. One of the larger families of proteins present in the membrane
is the ABC transporter proteins. Such proteins contain a conserved ATPbinding cassette domain that allows these protein transporters on the
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membrane to bind with ATP[7]. The protein composition of a plasma
membrane, along with phospholipid and sterol content, greatly determines
the degree of permeability allowed by the membrane. In the most simple
of cases, small solutes passively diffuse across the membrane without an
expenditure of ATP. Not surprisingly, most small solutes are more
hydrophilic in chemical composition than hydrophobic. A more specialized
method of passive diffusion involves the use of channels that span the
width of the bilayer. Like most eukaryotes, yeast membranes include a
potassium, K+, channel that closely regulates potassium efflux. The next
prevalent method of solute transport in yeast cells involves the active
establishment of an electrochemical gradient, known as secondary
transport. The proteins involved in secondary transport are thereby
responsible for establishing and maintaining a homeostatic gradient at all
times. In uniport secondary transport, the gradient is created by the
passing solute and only transports one type of solute. In yeast cells, this
is often observed with monosaccharide transport. In a symport system,
the carrier protein co-transports two molecules in the same direction. Ion
secondary transport often occurs concurrently with the influx of sodium
ions across the membrane. Likewise, symport proteins regulate the
transport of larger disaccharide molecules. Lastly, in antiport transport,
two solutes are simultaneously transported in opposite directions.
Typically, this maintains the electrochemical potential within and outside of
the cell. A classic example of this particular type of transport is found in
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most eukaryotic cells, in the form of an evolutionarily conserved sodiumproton pump. With the influx of sodium cations, there is an efflux of
protons[7]. Understanding these modes of protein-mediated transport
provides critical insight in studying membrane homeostasis.
In almost all plasma membranes, the sterols play an integral role in
membrane homeostasis and overall permeability. Geometrically, sterols
interrupt lipid interactions and layering within the membrane, thereby
contributing both a degree of asymmetry and plausibly influencing integral
protein activity[7]. In yeast, the ergosterol biosynthesis pathway largely
directs sterol integration in the plasma membrane. Ergosterol is
analogous to the mammalian sterol, cholesterol. Like most sterols,
ergosterol is formed in the ER, and is synthesized from melvonic acid[7].
This sterol is of particular interest since many naturally occurring
environmental toxins complex with ergosterol, consequently disrupting the
plasma membrane bilayer. Interestingly, the gene products found within
the ergosterol biosynthesis pathway are currently targets of interest in
antifungal research. Perhaps one of the most effective approaches in
antifungal technology seeks to deplete the plasma membrane of its
structural integrity and selective permeability. Sterol binding by a natural
or clinical drug, currently azole-based, may cause disruption of the plasma
membrane. Understanding the underlying genetic mechanisms of
membrane homeostasis thus proves not only to be of genetic value, but,
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perhaps more importantly, holds great clinical value in developing more
effective antifungals.
THE YEAST PDR NETWORK
My research project attempts to understand some of the underlying
genetic mechanisms of plasma membrane resistance to naturally
occurring antifungal compounds. Perhaps one of the largest genetic
contributors to observed phenotypic membrane resistance, in yeast, is the
pleiotropic drug resistance gene network. The PDR network contains a
family of genes that participate in cellular activities, such as tolerance to
membrane disturbing compounds and functioning in membrane
transport[1]. Interestingly, several transcription regulators control the
expression of genes functioning as membrane efflux pumps. Such pumps
have been shown to provide a mechanism of drug resistance. Consider
the transcriptional regulators PDR1, PDR3, PDR7, and PDR9. Together,
they control the gene expression of PDR5, whose encoded protein
belongs to the ABC protein family and functions as a drug efflux pump[1].
PDR1 and homolog, PDR3, regulate YOR1, SNQ2, and STE6. Snq2p is
analogous to the Pdr5p efflux pump and most likely functions in the
cytosol. Together, these proteins are responsible for observed resistance
to various toxic compounds such as cycloheximide, triterpene glycosides
(TTGs), and antimycin[7]. Not surprisingly, many PDR proteins are
capable of transporting compounds through their ATPase activities.
Additionally, the YAP regulatory stress response network contributes to
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genetically controlled drug resistance[7]. It is believed that both the PDR
and YAP networks function closely together to establish drug resistance.
Mechanistically, many antifungal drugs target the electron transport
chain of the mitochondria, consequently disrupting ATP production and
thereby eliminating membrane homeostatic processes. Interestingly,
though, in cases of phenotypic resistance to antifungals, signals from
distressed mitochondria activate the PDR network. Specifically, PDR1
and PDR3 transcription factors undergo substitution mutations and results
in an upregulation of PDR5[3], which consequently leads to an
overexpression of membrane efflux pumps. Moreover, both the loss of
mitochondrial genes and the inner mitochondrial membrane protein,
Oxa1p, results in the upregulation of PDR3[1]. Furthering these findings, in
2000 it was observed that phenotypic resistance to the clinical antifungal,
mucidin, was the result of a mutation in the PDR3 gene[4]. When
compared to wildtype strains, deletion strains for the PDR1 and PDR3
genes demonstrated the highest degree of drug sensitivity[4], suggesting
these homologs are critical in pleiotropic drug resistance. Furthermore,
when a wildtype strain was grown in the presence of mucidin, there was
almost a three-fold increase in the concentration of the Pdr5p efflux pump
protein when compared to control cells[4].
In general, it is believed that the PDR network is responsible for
both efflux pumps and lipid membrane trafficking specific to drug
resistance. When considering the effects of both deleting the PDR1 and
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PDR3 genes and the normal homeostatic processes involved with the
plasma membrane, it becomes apparent that disturbing either the efflux
pumps or ATP binding cassette proteins will lead to phenotypically
observed sensitivity. Moreover, given that the PDR network and related
genetic pathways are numerous, a disturbance in any one particular target
gene transcript could disturb drug resistance. Moreover, it is likely that
some of the current uncharacterized targets of the PDR network
specifically contribute to either the efflux pump, or are involved in lipid
membrane trafficking and/or cytosolic membrane ATP activity.

IDENTIFYING THREE PDR PROTEINS of
UNKNOWN MOLECULAR FUNCTION
In an attempt to further understand the underlying genetic
mechanisms of pleiotropic drug resistance, a deletion screen in the
Erdman lab (Syracuse University) attempted to understand phenotypic
resistance to glycosides of triterpene C30 compounds. These compounds
are saponins that occur widely in plants as defense mechanisms.
Amongst these naturally occurring defense compounds are chaconine,
glycyrrhizic acid, gummosogenin, machaeric acid, and machaerinic acid.
These compounds disturb plasma membranes in a variety of ways,
including association with ergosterol molecules within the bilayer.
Analogous to nystatin, the plasma membrane ATPase and chitin synthase
activity are often pathway antifungal targets in sterol-rich domains.
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Interestingly, it has been suggested that sterol-rich regions contain chitin
synthases, while sterol-poor domains contain ATPases[7]. In either case, it
becomes evident that drugs complexing with sterol bilayer molecules
disturb normal membrane homeostatic processes.
A high copy suppression screen was carried out in an attempt to
identify and isolate gene interactions with SIP3, whose protein resides in
the plasma membrane. SIP3 is known to positively associate with SNF1,
a protein kinase involved with both nuclear histone phosphorylation and
glucose repression states[2]. The SIP3 gene ontology (GO) molecular
function classifies the gene for its involvement in transcription cofactor
activity and is specifically responsible for the positive regulation of
transcription from the RNA polymerase II promoter[2]. A high copy
suppression screen involves the overexpression of candidate genes, and
in this case positively identifies genes that influence resistance to TTG. In
this particular screen, the SIP3 strain exhibits super sensitivity to TTG. In
an experiment conducted by Gary Franke of the Erdman lab, 5,200
transformant colonies and high copy plasmids were screened by
transforming a yeast 2µ library into a SIP3 strain. Of the 5,200
transformant colonies screened for TTG sensitivity, 31 high-copy
suppressors were isolated. 17 of these were retested and shown to cause
TTG resistance. Of these 17, a total of 11 unique high-copy suppressors
were isolated. With an average of 2-3 genes per insertion, and a yeast
genome spanning approximately 6,000 genes, an estimated 11,700
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genes, or nearly 2x the genome, were screened for TTG resistance(ttgR)
phenotypes.
Of the candidate high-copy suppressors of the sip3∆strain, three
genes of unknown molecular function were identified with coding
sequences found in the following ORF’s: YGR035c and YPR145c-a.
Among other suppressor genes identified, PDR16 and LAG1 were
isolated, both regulated by the PDR network. Of the total candidate
suppressor genes, most fell under three general molecular functions,
namely pleiotropic drug resistance, vesicular trafficking, and stress
response. A further investigation and understanding of the PDR network
suggests that YGR035c and YLR346c are direct target genes of unknown
molecular function regulated by PDR8, YRR1, and/or YRM1. It is likely
that TTG resistance may be caused by an overproduction of pleiotropic
drug resistance proteins. For the most part, PDR1/3, YRR1, and YAP1 all
contribute to drug resistance. Most of the PDR genes encode either ABC
transporters, MFS permeases, or are involved in membrane metabolism.
YGR035c, YLR346c, and YPR145c-a are regulated by the PDR network
due to their observed phenotypic behaviors in response to membrane
disturbing compounds. YGR035c, YLR346c, and YPR145c-a are
members of a small multigene family, sharing conserved KITRYDL and
VITRHDL domains respectively. A triple mutation of these genes led to an
observed decrease in membrane homeostasis, when cells were treated
with the membrane disrupting detergents digitonin, ketoconazole, and
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TTG. The same trends were observed when cells were exposed to the
drugs cycloheximide, 4-NQ, SDS, and in the presence of the clinical
antifungal drug amphotericin B. The observed phenotype suggests that
this set of novel proteins regulates membranes in response to membranealtering conditions, as an observed fifty-fold increase in membrane
sensitivity of the triple mutant was observed for membrane acting
compounds. For their observed phenotypes and apparent roles in the
pleiotropic drug resistance network, the YGR035c, YLR346c, and
YPR145c-a genes were respectively termed PDR19, PDR20, and PDR21.
In order to help determine the molecular function(s) of these PDR
proteins, a GAL4 two-hybrid system is being used to screen for proteins
that may associate with the PDR 19/20/21 family proteins and help
mediate their cellular functions.

THE YEAST TWO-HYBRID SYSTEM
In order to determine the functions and molecular activities of the
PDR 19 and 20 proteins, the yeast two-hybrid system is being used to
investigate their possible relationships with other proteins involved in
membrane homeostasis. This technique allows for the identification of
interacting proteins, by which a positive interaction signifies a similar
cellular function and residence in a common protein complex. Aside from
sequencing a protein of unknown molecular function, it is often equally
important to identify interactions with other proteins as a next step in trying

12
to uncover its function(s). While it is largely believed that the suspect PDR
proteins are involved in pleiotropic drug resistance, the yeast two-hybrid
system will help identify interactions with other proteins.
In almost every process that occurs in the cell, there is an
interaction between at least two, and often several, proteins. Protein
interactions vary widely and occur in various processes such as
transcription, translation, vesicular trafficking, membrane homeostasis,
and cellular signaling. Protein-protein interactions play a pivotal role in
normal cellular growth and homeostasis. In the case of protein
modifications, for example, there is necessarily a protein-protein
interaction based on both chemical and physical attractions. Protein
kinases, glycosyl transferases, and phosphatases interact with their
specific protein counterparts and allow for the transfer of a functional
group from a specific amino acid[6]. Several genetic diseases are often
manifested through aberrant protein-protein interactions, such as sickle
cell anemia. In the case of the pleiotropic drug resistance, the function of
the PDR network is dependent upon gene products interacting with
specific membrane proteins to elicit membrane homeostasis.
The yeast two-hybrid system involves the use of in vivo DNA
transcriptional machinery. In particular, the system allows for the
characterization of a protein of unknown molecular function based on an
observed control protein interaction. The GAL4 gene and associated
transcriptional machinery is what ultimately allows for the success of the
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two-hybrid system. This constructed system makes use of two key
concepts in gene transcription, regarding two DNA domains. The DNA
binding domain recruits factors that bind directly to the promoter cis
region, while the activation domain actually initiates transcription. In
particular, transcription of GAL4 dependent promoters will not occur
unless the DNA binding domain (DBD used in text to follow) is associated
with a corresponding activation domain (AD used in text to follow).
Interestingly, these two DNA domains do not need to be physically linked
through covalent interactions[6], thus allowing for the construction of a twohybrid system. Fields and Song first proposed and demonstrated this
mechanism through their use of SNF1 and SNF4[6]. By creating fusion
chimeras where SNF1 was fused to the DBD and SNF4 was fused to the
AD, formation of a functional transcription factor was detected through
phenotypic expression of the GAL4 reporter[6]. This experiment proves
that two related proteins will associate through non-covalent interactions.
By fusing a “bait”/suspect protein to the DBD and a known prey
protein/library to the AD, successful association leads to reporter gene
expression through the transcription of the reporter GAL4 gene. In the
event that the two proteins do not bind to one another, an interaction will
not occur. Thus the AD will not associate with the DBD, which will not
result in transcriptional activity.
As with any system, the two-hybrid system does have
disadvantages. Firstly, the construction of a two-hybrid system involves
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the transformation of a protein of interest fused to the DBD into a yeast
strain containing a reporter gene. If the fusion protein causes transcription
on its own, it is said to autoactivate the reporter. In this particular case,
the protein cannot be used as an effective “bait” in screening a library of
AD fusion cDNA clones[6]. With any system that involves the use of
chimeras, it is always possible for the native quaternary protein
conformations to become compromised during genetic manipulation. If
the native conformations of the bait or prey protein are changed, it is quite
likely that the proteins may not interact as they normally would do so in
vivo. Another apparent disadvantage in using the two-hybrid system is the
obvious fact that protein-protein interaction occurs in yeast cells. In
studying proteins from other organisms by this system, it is essential that
they be able to fold correctly in yeast[6], as failure to do so will undoubtedly
disturb native covalent interactions. Yet another disadvantage with the
two-hybrid system is that the only measurable indication of interaction is
the phenotypic expression of the reporter gene. Although fairly unlikely, it
is possible that a third protein could bridge the two fusion proteins, thereby
initiating transcription of the reporter[6].
Most of the aforementioned disadvantages are minor when
considering the biological value of the system’s advantages. Perhaps the
most obvious advantage is the fact that the two-hybrid system employs
the use of DNA transcriptional domains and associated machinery. Unlike
traditional biochemical approaches, protein-protein interaction in this
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construct occurs in vivo. Since detection does not occur in vitro or through
bacterial expression, low affinity protein-protein interactions are noted
more frequently by transcription of the reporter[6]. In other words, there is
a significant degree of amplification in the form of the reporter, whereas
some biochemical assays may not necessarily isolate these transient
interactions. Perhaps the greatest advantage of the system is that a
known protein interactor can be used to functionally characterize an
unknown protein in an in vivo environment. This property makes the yeast
two-hybrid system an effective tool in characterizing cascade signaling or
even targets of cellular networks, such as the pleiotropic drug resistance
network. The speed and relative ease in creating fusion proteins makes
this system an ideal tool in the characterization of protein interaction.

EXPERIMENTAL APPROACH: Use of the GAL4
two-hybrid system to attempt to identify proteins
associating with PDR 19 and PDR20
Perhaps one the most critical decisions in designing a two-hybrid
system is the choice of the vector system. The most frequently used DBD
and AD containing vectors are based in the GAL4 system, as the reporter
gene activity is easily evaluated. However, in some cases other vectors
are used, such as the LexA system[6]. Nonetheless, it is important to use
a bait vector with certain features. In this case, the pAS II vector was
used. The pAS II plasmid contains a hemaglutinin epitope tag, inserted in
the GAL4 DBD reading frame[6], which allows for HA protein tagging and
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visualization by immuno-blot. Most plasmid vectors in yeast two-hybrid
systems also include a selectable nutritional marker, as is the case with
the TRP1 gene in pAS II. This ultimately allows for selection upon
transformation on synthetic complete media in the absence of tryptophan.
The pAS II plasmid vector used in construction of the PDR two-hybrid
system is of the following type: DBDGAL4 HA epitope, TRP1. In the case
of the “prey”/library plasmid vector, pACT II was used, which contains the
GAL4 activation domain. As with pAS II, pACT II also allows for nutritional
selection, but is selective on synthetic complete media minus leucine.
Specifically, pACT II consists of the following selectable markers: AD GAL4
HA epitope, LEU2.
One obstacle that the GAL4 yeast two-hybrid system must
circumvent is the inherent behavior of GAL4 and GAL80 in the presence
or absence of galactose. As is the case with all yeast genes, a functional
TATA box is located upstream of the gene. The promoter region of a
functional gene typically includes the TATA box and its associated cisacting transcriptional elements. One of the most prevalent cis-acting
transcriptional elements present are the upstream activating sequences
(UAS). These sequences in yeast bind two regulatory proteins: Gal4p
and Gal80p. These two regulatory proteins control galactose metabolism.
In the presence of galactose, Gal4p binds to the GAL elements within its
corresponding UAS[6]. However, in the absence of galactose, Gal80p
binds to Gal4p, thereby blocking transcriptional activity. Obviously, in
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constructing a yeast two-hybrid system, it is necessary to avoid this
natural interaction between the two GAL proteins. To do so, the twohybrid system must contain deletions of the GAL4 and GAL80 genes,
which consequently results in slower growth[6].
In order to construct the PDR 19/20 two-hybrid system, the
following yeast strains were used: YSE859 Y190; MATa gal4 gal80 his3
trp1-901 ade2-101 ura3-52 leu2-3, -112 URA3::Gal-lacZ,
Lys2::GAL(UAS)-HIS3 and YSE32 Y187; MATα gal4 gal80 his3 trp1-901
ura3-52 leu2-3,-112 URA3::GAL-LacZ.
The yeast strain Y190 was transformed with the plasmid pAS II and
PDR19 and 20 clones: YLR B-1, YLR A-4, YGR A-2, and YGR B-1. This
was done using a standard plasmid transformation into yeast protocol.
2mL of Y190 yeast cells in YPD liquid media were grown overnight at
30˚C in an incubator. 500µL of cells were spun down and the liquid media
was aspirated. 100µL of one-step buffer (1mL stock: 200µL 2M LiAc,
800µL 50% PEG, and 7.69 µL β-Mercaptoethanol) was added. 5 µL of
salmon sperm DNA were added with 1 µL of the “bait” plasmid, pASII. As
mentioned, pAS II contains the DBDGAL4. After heat shocking for 30
minutes, the cells were plated on synthetic complete media minus
tryptophan. The pAS II carries TRP1 as a selectable nutritional marker.
Transformants carrying the plasmid will therefore be able to grow on the
SC-Trp media.

18
The Y187 strain was successfully transformed with pACT II,
containing the ADGAL4, using the transformation protocol. Since pACT II
contains a LEU2 nutritional selection marker, the cells were plated on SCleu media. Rather than co-transforming the two fusion strains onto a SCleu-trp plate, a modified replica plating technique was used. The Y190
transformants were patched onto a SC-leu-trp plate and physically mated
with the Y187 strain, containing the pACT II activation domain plasmid.
Upon incubation at 30˚C, for two days, positive growth was noted on the
SC-leu-trp plate signifying a successfully constructed two-hybrid system
(See Appendix1). Eventually, a library screen will be carried out,
searching for proteins that interact with the novel PDR 19 and PDR 20
proteins. Isolating such protein interactions will increase understanding as
to what the exact molecular functions of these novel proteins are and how
they participate in membrane homeostasis.

CONFIRMATION of NEGATIVE AUTOACTIVATION TESTS
The constructed yeast two-hybrid system is largely based on the
transcriptional activity of the reporter GAL4 gene. Since the system
involves the control clones and the “bait” pAS II DNA binding domain
plasmid, it is important to make sure that transcription is in fact due to the
interaction between two interacting proteins and not DBD fusion activation.
The Y190 strain used in the early transformations contains a reporter gene
used to assess autoactivation, namely the HIS3 gene. Activation of the
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reporter would be due to autoactivation by the DBD/ PDR19 and/or 20
fusions, thereby initiating transcription of the reporter gene.
The presence of the reporter HIS3 gene allows for nutrional
selection on SD media in the presence of varying concentrations of the
HIS3 protein competitive inhibitor, 3-aminotriazole. Following collection
and cultivation of independent transformants for the bait plasmids,
autoactivation was studied by observing growth on SD-His media.
Theoretically, an increase in the concentration of the histidine enzyme
should lead to an increase in the concentration of histidine even in the
presence of the 3-aminotriazole competitor, hence growing on SD+40mM
aminotriazole. This of course reflects activation by the DBD-fusions, and
is thereby indicative of autoactivation in the constructed GAL4DBD-PDR
fusion proteins.
In order to assess for autoactivation in the PDR19/20 yeast twohybrid construct, growth relative to known interactors were compared. For
the positive growth control, the YSE1340 strain (Y190 carrying an Erdman
lab constructed bait plasmid PXL1-DBD) plus OSE3-AD was patched on
SD + 40mM aminotriazole and incubated for 24 hours. This yielded
positive growth on the media, as activation of the GAL-HIS3 promoter lead
to an increase in the concentration of the His enzyme, thereby increasing
the concentration of free histidine. For the negative growth control,
YSE1340 plus the pACT II carrying the empty AD was assessed. After 24
hours of incubation, no growth was observed. In the mated Y187/859
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(containing PDR/pACT II) no activation of the promoter was observed, and
hence no observed growth. Upon patching on SD+40mM aminotriazole,
there was no observed growth for all Y187/859 strains containing the
PDR19/20 baits and empty activation domain vector (See Appendix 1b).
This indicates that these fusions can be used for future screens using the
system.
Currently, plasmid sequencing of the GAL4DBD-PDR fusion
proteins is in process to help confirm proper cloning of the bait proteins
prior to library screening (See Appendix 2).

FUNSPEC ANALYSIS of TTG RESISTANCE and SENSITIVITY AMONG
NON-ESSENTIAL S.cerevisiae GENES
In studying the composition of cell membranes, at least two
unanswered questions can target the direction of research. First, how do
fungi cope with naturally occurring products present in their environments,
which may be toxic to them through affecting their cell membranes? Many
such natural products are thought to exist in plants as defense
mechanisms. Secondly, how do eukaryotic cells in general maintain
membrane homeostasis in the event of environmental challenges? The
yeast genome is comprised of roughly 6,000 genes. Nearly 30% of yeast
ORF’s encode membrane proteins, a statistic that should come at no
surprise considering the number of different compartment membranes in
eukaryotic cells. Every compartment membrane has a genetically
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controlled mechanism that maintains membrane homeostasis. Currently,
there are approximately 900 yeast ORF’s with unknown functions, some of
which could function in membrane homeostasis. This appears to be the
case for the recently isolated family of proteins PDR 19/20/21.
One of our aims is to understand how eukaryotic cells maintain
membrane homeostasis in the face of environmental challenges. Of the
many natural products fungi encounter, some glycosides of triterpenes are
known to present a possible challenge to membrane integrity and overall
homeostasis. Triterpenes are natural C30 compounds, whose glycosides
are saponins that occur in plants as a possible defense compound. TTGs
disturb membranes through such mechanisms as sterol binding, often
rendering the membrane more permeable. Studying membrane disturbing
compounds and their associated effects on membrane disruption allows
for further insight into both the pleiotropic drug resistance network and
how vesicular trafficking proteins maintain membrane homeostasis.
Interestingly, wild type yeast backgrounds differ in resistance to TTGs.
For instance, the wild type W303 strain is sensitive, while BY4743 and its
derivatives are not as sensitive. In a previous screen in the Erdman lab,
4,851 deletion strains of the BY4743 background were screened, of which
991 strains demonstrated a degree of sensitivity or resistance to TTGs
relative to the wild type strains. Of the 991 strains, 110 were
supersensitive, 276 were sensitive, 407 were moderately sensitive, and 53
deletion strains were weakly sensitive. A total of 131 resistant strains
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were isolated. Interestingly, it is estimated that 80% of the TTG
phenotypes are linked to kanMX. KanMX was systematically used to
replace ORFs, in essence establishing an ORF knock-out collection. The
results from the deletion screen are of interest, for there must be an
underlying mode of genetic control governing the range of observed
phenotypic sensitivities. In an attempt to further understand and classify
these results, a bioinformatics tool, Funspec (T. Hughes Lab, U. Toronto)
was used[2]. Funspec is a program that queries yeast databases with an
input set of genes (in our case the genes whose deletion leads to TTG
sensitivity or resistance), and compares their MIPS (Munich Information
Center for Protein Sequences) and GO (Gene Ontology) classifications to
those of all the genes present in the yeast genome. Such classifications
take into consideration the molecular function, cellular component,
subcellular localization, and protein complexes.

TTG RESISTANCE
In querying yeast databases with an input set of genes whose
deletions confer resistance, there were several common MIPS and GO
classifications that perhaps offer insight into drug resistance and cellular
processes controlling membrane homeostasis. Interestingly, the greatest
possibility value (p) for GO biological processes showed that most genes
are involved with the sterol biosynthetic process, phospholipid
translocation, and steroid biosynthetic processes in general. This finding
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is consistent with the notion that TTG resistance employs alternative
proteins of sterol biosynthetic pathways, and perhaps thereby physically
resists alterations in the lipid bilayer. Not surprisingly, one of the main
targets of TTGs is in fact the bilayer integral sterol molecule. Sterols,
among other functions, are responsible for controlling the fluidity of the
lipid bilayer. TTG targeting of sterol molecules disturbs membranes
through a variety of mechanisms, most notably TTG complexes to
ergosterol. The following ergosterol genes are involved with resistance:
ERG2, ERG3, and ERG6, perhaps conveying resistance to TTGs (See
Appendix 3a).
Additionally, several of the TTG resistant genes are involved with
phospholipid translocation. DRS2, DNF2, and LEM3 all function to
maintain membrane homeostasis. DNF2 and DRS2 are both
aminophospholipid translocases or flippases that are involved in
endocytosis, protein transport, and cell polarity. Both are type 4 P-type
ATPases. KES1 and CYB5 are also involved with membrane
homeostasis and TTG resistance. KES1 is a member of the oxysterol
binding protein family that regulates Golgi complex secretory functionality.
Like the other proteins in its functional class, Kes1p functions on the
cytosolic side of the plasma membrane. In the case of CYB5, Cytochrome
b5, it is involved in sterol biosynthetic pathways, and specifically donates
electrons to support C5-6 desaturation[2].
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As previously mentioned during the discussion of the PDR network,
plasma membrane resistance is often induced by signals produced from
dysfunctional mitochondria. Loss of the inner mitochondrial protein Oxa1p
results in a generated signal that increases the concentration of PDR5, a
membrane efflux pump of the ABC superfamily[3]. In other cases,
substitution mutations within the PDR1 or PDR3 proteins result in
observed pleiotropic drug resistance, by again increasing the
concentration of the PDR5 efflux pump protein. Not surprisingly, when
looking at the bioinformatics of cellular respiration and mitochondrial
function involved in TTG resistance, almost all genes encode proteins that
are functionally involved in processes that occur within the inner
membrane of the mitochondria. IMP1, CYC3, and COR1 are three prime
examples of this observation. IMP1 is a gene whose protein functions in
the catalytic subunit of the mitochondrial inner membrane peptidase
complex[2]. In the case of COR1, the protein functionally resides in the
subunit of the ubiquinol-cytochrome c reductase complex, and is again a
component within the inner membrane electron transport chain[2].
Aside from cellular functions involving membrane phospholipids,
sterol biosynthesis, and mitochondrial functionality, TTG resistance also
seems to be characterized by changes in cell polarity and cellular
signaling. Genes involved in these processes include membrane protein
genes such as LEM3 and cdc42p-activated signal transducing kinases
such as STE20. When considering all of the genes above, it becomes
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clear that TTG resistance is not controlled by any one particular gene, but
rather is a collaborative genetic product of several networks. Such
networks include ergosterol biosynthesis, mitochondrial functionality, PDR,
YAP, and cellular signaling. Additionally, several novel genes of unknown
function have been found as a result of both TTG screens and
bioinformatic approaches. Such genes include YPL191c, YBL089w,
YFL006w, YBR255w, YKL023w, and YNR047w. It is possible that one or
more of these genes function in one of the key genetic pathways
mentioned.
TTG SENSITIVITY
Upon evaluating the TTG sensitive genes, an interesting trend
develops. Although many of the cellular functions fall under the same
category, the individual genes involved differ from those expressed in TTG
resistant phenotypes. Consider TTG sensitive genes involved in
membrane phospholipids and sterols. Unlike genes involved in
resistance, a different set of ergosterol genes are involved in sensitivity.
Particularly, the following ergosterol genes are involved: ERG4 and
ERG5. Additionally, OSH3 is involved with membrane sensitivity (See
Appendix 3b). Interestingly, TTG sensitivity employs the use of OSH3, an
oxysterol-binding protein involved in sterol metabolism, whereas TTG
resistance entails the expression of OSH4/KES1. OSH4/KES1 is involved
in the negative regulation of the Sec14p, which is a phosphatidylcholine
transfer protein. OSH4 de-regulates Golgi vesicular trafficking that is
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regulated by the Sec14p [2], and overall perhaps influences lipid
distribution within the membrane.
Interestingly, TTG sensitivity also returned genes involved in cell
wall assembly and stress response proteins. Such is the case with SFL1,
which is an activator of stress response genes[2]. Likewise, GAS1 is a
gene required for cell wall assembly, as its protein specifically functions as
a glycophospholipid-anchored surface protein. Perhaps one of the most
interesting observations concerns the killer toxin resistance genes: FYV4,
FYV6, and FYV12. These genes, when deleted, cause TTG sensitivity,
even though the precise molecular functions of these proteins are
currently unknown. It appears, though, that these genes are activated in
response to K1 killer toxin. Perhaps the activation of these genes is in
response to a disturbance that mimics TTG membrane disruption. In fact,
KI is a perforating protein that destroys sensitive yeast cells[2]. In this
case, it appears that the FYV genes are not effective in resisting
membrane disruptions created by TTGs, but are activated as a result of
the yeast cell’s overall sensitivity. In resistant strains it was noted that
PDR genes and sterol biosynthetic pathways were activated.
Additionally, in TTG sensitivity, mitochondrial function and
respiration cellular functions are not observed. This offers further support
that sensitive strains do not activate the PDR1/3 genes through
mitochondrial signaling, which results in overexpression of the ABC type
PDR5 efflux pump. If the functional classes of genes enriched in the TTG
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screen are compared between the resistant loci and sensitive loci, several
differences are noted. Generally, TTG resistant loci encode ribosomes,
lipids, isoprenoids, and sterols. TTG sensitivity-causing loci involves
functional classes such as transport ATPases, lipids, sterols, and ion/pH
homeostasis. When considering these two groups of functional classes, a
trend becomes apparent. TTG resistance generally involves ribosomal
machinery and translational events, suggesting that there is an active
attempt by the cell to express gene products that operate to maintain
membrane homeostasis. Moreover, different ergosterol pathways are
used to resist TTG membrane disturbances. With TTG sensitivity,
different functional classes are involved, in particular ATPases. As
previously mentioned, TTGs complex with sterols and perhaps disrupt
ATPase activity. Curiously, sensitivity maybe related to cellular attempts
to replenish ATPase activity, while a degree of resistance entails a
different sterol biosynthetic pathway to produce un-complexed sterols.
While this has not been proven, there is strong supporting bioinformatic
evidence, as will be discussed in the next section.

ERGOSTEROL BIOSYNTHESIS in RESPONSE to TTG
In analyzing the results of the two queries involving TTG resistance,
some mechanisms through which membrane homeostasis may be
disrupted become evident. As illustrated in the results above, TTG can
associate with ergosterol, possibly leading to an increase in ergosterol
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concentration by the cell as a compensatory mechanism. Interestingly,
different components of the ergosterol biosynthetic pathway are involved
in the resistant strains, which suggest possible resistance due to
byproduct formation. Inactivation of ERG3/6/2 and KES1 cause
phenotypic TTG resistance, while ERG4/5 and the oxysterol binding
protein OSH3 lead to sensitivity.
A closer investigation of the ergosterol biosynthetic pathway
reveals that genes involved in TTG resistance may produce enol
byproducts, which could lead to an increased production of sterols.
Specifically, ERG 6 is capable of producing dienol, trienol, and tetranol
byproducts. ERG2 likewise produces enol, dienol, and trienol forms.
Lastly, ERG3 produces byproduct sterols existing in both enol and dienol
forms.
When considering these results, it becomes apparent that while
TTG complexes with ergosterol, sensitive strains may only activate
ERG5/4, which consequently increases the concentration of ergosta5,7,22-trienol (ergosterol). The ergosterol molecules produced are
identical to the integral ergosterol molecules within the bilayer, resulting in
further complexing by TTGs. In resistant strains, the ergosterols are not of
the ergosta-5,7,22-trienol form, and exist in the enol byproduct forms
previously mentioned. Interestingly, in resistant strains the concentrations
of these byproduct enol forms increase upon exposure to TTG, suggesting
that these forms are perhaps incapable in complexing with TTG, thereby
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leading to increased phenotypic resistance. Sensitive strains cannot
produce any other form of ergosterol, which perhaps leads to the
observed sensitivity.
In a related observation, azole drug mediated fungal targeting
currently seeks to target ERG11. Azole targeting in yeast targets a
cytochrome P450 which is a C14α-demethylase, encoded by ERG11.
Targeting the gene product of ERG11, namely C14α-demethylase, confers
sensitivity. Resistance, however, can occur via an alternative pathway of
a mutated ERG3 gene. In this case, normal sterol production is altered
during subjection to the antifungal drug, consequently developing a
deficiency in a sterol desaturase, and the cell thereby resists membrane
degradation. Another focus involves further analysis of the ERG4 gene,
one of the final genes in the pathway, responsible for the sterol C-24
reductase. Upon deletion of this specific gene, ergostan 5,7, 22, 24tetraen-3β-ol, a precursor to ergosterol, accumulates within the
membrane, which might explain the observed drug hypersensitivity.
Interestingly, our investigation pertaining to the suppression
screens used with TTG to analyze compensatory mechanisms in the
absence of ergosterol produces similar drug resistance patterns as with
previous antifungal tests. This, once again, suggests that there is a broad
cellular response to drugs that act as membrane disturbing compounds.
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CONCLUDING REMARKS
The plasma membrane is one of the most critical structures in cells.
Through regulation and homeostatic measures, the membrane resists
environmental challenges, such as naturally occurring toxic compounds.
In an attempt to further understand the underlying genetic mechanisms,
recent genetic screens in yeast for plasma membrane homeostatic
proteins identified three related proteins of unknown molecular function
that participate in these processes. These proteins, termed PDR19,
PDR20, and PDR21 for Pleiotropic Drug Resistance, are each
approximately one hundred amino acids in size and share a small
conserved domain. The coding genes for this set of proteins may be
found in the ORFs YGR035c, YLR346c and YPR145w-a, respectively.
Functionally, these proteins appear to be effectors of the PDR network, as
a triple mutation of these genes led to an observed decrease in membrane
homeostasis, when treated with the membrane disrupting reagents. The
observed phenotype suggests this set of novel proteins acts to functionally
resist/regulate membranes in response to membrane-altering conditions.
Further analyses suggest a functional role not only in chemical resistance,
but perhaps also in membrane composition.
(i) In order to determine the functions and molecular activities of
the PDR proteins, the yeast two-hybrid system will be used to investigate
their relationship with other related proteins involved in membrane
homeostasis. This technique allows for the identification of interacting
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proteins/components, and is also a tool to manipulate native interactions.
A yeast two-hybrid system containing the PDR19/20 proteins has
successfully been constructed, although screening for interactors has not
yet occurred. That this system can be used has been confirmed through
negative autoactivation tests involving a related protein from a modified
Y187/Y190 mating strain and the pACT II activation domain plasmid
containing the ADGal4. Plasmid sequencing of the Gal4DBD-PDR fusion
proteins is in process to help confirm proper cloning of the bait proteins in
addition to library screening.
(ii) One of the many aims in studying membrane homeostasis is to
further understand resistance and sensitivity associated with exposure to
naturally occurring toxic compounds. Of the many natural products, fungal
cells may encounter some glycosides of triterpenes are known to present
challenges to membrane integrity and overall homeostasis. In a screen
for the effects of TTG membrane disruption, 4,851 yeast deletion strains
were screened, of which 991 demonstrated a degree of sensitivity or
resistance. In attempt to categorize and further understand the genetic
components involved with these phenotypes, a bioinformatic tool was
employed. Funspec analysis demonstrated that there are distinct genetic
candidates and pathways involved in mediating resistance or sensitivity to
membrane disturbing compounds. Most notably, the ergosterol
biosynthetic pathway and PDR networks were synonymous with
phenotypic resistance.
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Understanding the homeostatic processes and resistance patterns
involved with drug challenges holds significant clinical importance. Fungal
infections are especially devastating to pediatric patients and those with
immunosuppressed systems, such as AIDS patients. Through an
understanding of the biosynthetic pathways essential for membrane
homeostasis, it is quite possible that novel non-invasive treatments for
fungal infections may be developed. Such antifungal activities would
target specific components and pathways essential for membrane stability.
Identifying and isolating the novel proteins involved in these pathways is
an important step in developing such treatments. In addition, such studies
also lead to a greater understanding of our own cells. When we consider
that one of the greatest challenges in drug design today is cellular uptake
of compounds by the plasma membrane, even the smallest of discoveries
may one day have a much more profound impact. Our findings regarding
plasma membrane homeostasis mechanisms will contribute to a much
larger collection of biomedical discoveries that are medically important to
drug design and delivery mechanisms.

33
SOURCES CITED and CONSULTED
[1] Balzi, E., & Goffeau, A. (1995). Yeast multidrug resistance: the PDR
network [Electronic version]. Journal of Bioenergetics and
Biomembranes, 27(1), 71-76. doi:10.1007/BF02110333
[2] Grigull, Jorg, Naveed Mohammad, and Mark Robinson. Funspec.
http://funspec.med.utoronto.ca/.
[3] Hallstrom, T. C., & Moye-Rowley, W. (2000). Multiple signals from
dysfunctional mitochondria activate the pleiotropic drug resistance
pathway in Saccharomyces cerevisiae [Electronic version]. J. Biol.
Chem, 275(48), 37347-37356. doi:
doi:10.1074/jbc.M007338200From Pubmed
(10.1074/jbc.M007338200 ).
[4] Michalkova-Papajova, D., Obernauerova, M., & Subik, J. (2000). Role
of the PDR gene network in yeast susceptibility to the antifungal
antibiotic mucidin [Electronic version]. Antimicrobial Agents and
Chemotherapy, 418-420. doi:0066-4804/00/$04.00+0
[5] Pandey, A., & Mann, M. (2000). Proteomics to study genes and
genomes [Electronic version]. Nature, 837-846.
doi:10.1038/35015709
[6] Van Criekinge, W., & Beyaert, R. (1999). Yeast two-hybrid: State of
the art [Electronic version]. Biological Procedures Online, 1-38.
doi:10.1251/bpo16

34
[7] Van der Rest, M. E., Kamminga, A. H., Nakano, A., Anraku, Y.,
Poolman, Y., & Konings, W. (1995). The plasma membrane of
Saccharomyces cerevisiae: Structure, function, and biogenesis
[Electronic version]. Microbiological Reviews, 59(2), 304-322.

35
APPENDICES
Appendix 1:
a.)

Generation of a modified Y187/Y190 mating strain and the pACT II
activation domain plasmid containing the ADGal4. Yeast strain Y190 was
transformed with the “bait” plasmid pAS II and control clones: YLR B-1,
YLR A-4, YGR A-2, and YGR B-1 on synthetic complete (SC) media
minus Trp. Using a modified replica plating technique, the Y190
transformants were successfully mated with Y187 strain, containing the
pACT II activation domain plasmid, allowing growth on an SC-Trp-Leu
plate.

b.)

Evaluation of Autoactivation
Positive growth on SD + 40 mM
aminotriazole [Y1340+p507
(Pxl1p-Dse3 interaction)]

No growth of all Y187/859 strains
containing the PDR19
and PDR20 baits and an empty
activation domain vector

YGR A-2
YGR B-1
YLR B-1
YLR A-4
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Appendix 2:
1

4

5

YLR B-1 pASII (1)
YGR A-2 pASII (4,5)

Gel electrophoresis showing
plasmid DNA containing the
GAL4DBD-PDR fusion proteins.
Future plasmid sequencing will
help to confirm proper cloning of
the bait proteins.
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Appendix 3:
a.)
Key Funspec Analysis of TTG Resistant Genes
P<0.005 k: number of genes from the input cluster in given category.f: number of genes
total in given category.
MIPS Functional Classification
Category

p-value

In Category from Cluster

k

f

Ribosomal Proteins

5.91e-05

RPL19B RPS8A RPL23A RML2
RPL24B RPS24B RPS21B RPL14A
RPL8B RPL6B MRPL39 RPS18B
RPS10B RPS7B RPP2A

15 246

Tetracyclic/pentacyclic
triterpenes metabolism

0.004513

ERG3 ERG6 ERG2 KES1

4

36

ERG3 ERG6 ERG2 CYB5 KES 1

5

30

GO Biological Process
Sterol biosynthetic
0.0002188
process
Phospholipid
translocation

0.001286

DRS2 DNF2 LEM3

3

20

Steroid biosynthetic
process

0.001325

ERG3 ERG6 ERG2 KES1
STE14 STE20

4

26

RPL19B RPS8A RPL23A
RML2 NOP16 RPL24B

17 324

GO Cellular Component
Ribonucleoprotein
0.0001149
complex
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b.)

Key Funspec Analysis of TTG Sensitive Genes
MIPS Functional Classification
Category

p-value

In Category from Cluster

k

f

Homeostasis of protons

0.0006376

PPA1 VMA5 VPH2 VMA6
ATP15

5

47

Tetracyclic/pentacyclic
triterpenes metabolism

0.001938

ERG4 OSH3 YEH2 ERG5

4

36

0.001239

RSC1 RAD27 FYV6 RAD50

4

32

PPA1 VMA5 VMA6 ATP15

4

24

GO Biological Process
Double-strand break repair
via nonhomologous end
joining

GO Cellular Component
proton-transporting two-sector 0.0004013
ATPase complex

